Fulcrum Therapeutics, Inc. (FULC)
NASDAQ: FULC · Real-Time Price · USD
3.310
+0.050 (1.53%)
Nov 5, 2024, 1:19 PM EST - Market open
Fulcrum Therapeutics Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2017 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2017 |
| Revenue | 81.63 | 2.81 | 6.34 | 19.16 | 8.82 | - | Upgrade
|
| Revenue Growth (YoY) | 2582.55% | -55.77% | -66.90% | 117.19% | - | - | Upgrade
|
| Cost of Revenue | 74.27 | 71.8 | 76.78 | 69.7 | 59.04 | 71.07 | Upgrade
|
| Gross Profit | 7.36 | -69 | -70.44 | -50.54 | -50.22 | -71.07 | Upgrade
|
| Selling, General & Admin | 40.13 | 41.67 | 41.69 | 30.52 | 21.39 | 13.15 | Upgrade
|
| Operating Expenses | 40.13 | 41.67 | 41.69 | 30.52 | 21.39 | 13.15 | Upgrade
|
| Operating Income | -32.77 | -110.66 | -112.13 | -81.05 | -71.61 | -84.22 | Upgrade
|
| Interest & Investment Income | 12.54 | 13.33 | 2.69 | 0.21 | 0.79 | 1.54 | Upgrade
|
| EBT Excluding Unusual Items | -20.23 | -97.34 | -109.44 | -80.85 | -70.82 | -82.68 | Upgrade
|
| Merger & Restructuring Charges | - | - | -0.43 | - | - | - | Upgrade
|
| Pretax Income | -20.23 | -97.34 | -109.87 | -80.85 | -70.82 | -82.68 | Upgrade
|
| Net Income | -20.23 | -97.34 | -109.87 | -80.85 | -70.82 | -82.68 | Upgrade
|
| Preferred Dividends & Other Adjustments | - | - | - | - | - | 7.13 | Upgrade
|
| Net Income to Common | -20.23 | -97.34 | -109.87 | -80.85 | -70.82 | -89.81 | Upgrade
|
| Shares Outstanding (Basic) | 62 | 61 | 45 | 35 | 25 | 11 | Upgrade
|
| Shares Outstanding (Diluted) | 62 | 61 | 45 | 35 | 25 | 11 | Upgrade
|
| Shares Change (YoY) | 12.71% | 36.27% | 27.23% | 39.47% | 129.53% | 778.76% | Upgrade
|
| EPS (Basic) | -0.33 | -1.59 | -2.44 | -2.29 | -2.79 | -8.13 | Upgrade
|
| EPS (Diluted) | -0.33 | -1.59 | -2.44 | -2.29 | -2.79 | -8.13 | Upgrade
|
| Free Cash Flow | -12.62 | -91.47 | -99.01 | -80.19 | -55 | -40.43 | Upgrade
|
| Free Cash Flow Per Share | -0.20 | -1.49 | -2.20 | -2.27 | -2.17 | -3.66 | Upgrade
|
| Gross Margin | 9.02% | - | - | -263.73% | - | - | Upgrade
|
| Operating Margin | -40.15% | -3945.24% | -1768.12% | -422.97% | -811.64% | - | Upgrade
|
| Profit Margin | -24.79% | -3470.05% | -1732.43% | -421.89% | -802.66% | - | Upgrade
|
| Free Cash Flow Margin | -15.46% | -3261.07% | -1561.23% | -418.47% | -623.34% | - | Upgrade
|
| EBITDA | -30.88 | -108.49 | -109.72 | -78.54 | -69.23 | -82.16 | Upgrade
|
| D&A For EBITDA | 1.89 | 2.17 | 2.41 | 2.52 | 2.38 | 2.05 | Upgrade
|
| EBIT | -32.77 | -110.66 | -112.13 | -81.05 | -71.61 | -84.22 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.